# 1. Financial Performance ## A. Key Figures * **Consolidated Revenue:** **₹7,740 Cr** (+12% YoY) – highest ever quarterly * India Revenue: ₹51.4 Bn (+13%+ YoY) · EBITDA Margin: 14.5% (+340 bps YoY) * **Europe Revenue:** **€180 Mn** (flat YoY) · **EBITDA Margin:** **17.9%** (+200 bps YoY) * **Reifencom Revenue:** **€82 Mn** · **EBITDA Margin:** **8%** – best quarter * Consolidated EBITDA: ₹11.9 Bn · Margin: 15.3% (+40 bps QoQ, +160 bps YoY) * Net Debt: ₹13 billion (down from ₹26 billion) · Net Debt/EBITDA: 0.4x (down from 0.8x) ## B. Revenue Growth * **Record Topline Achieved:** Highest-ever quarterly revenue on standalone and consolidated basis, driven by strong domestic demand and favorable GST impact in India. * **India Momentum Strong:** Double-digit revenue growth and margin expansion reflect robust replacement market dynamics and pricing power. * **Europe Stabilized:** Flat revenues but meaningful margin improvement in Europe indicate effective cost discipline and operational leverage despite stagnant volumes. * **Reifencom Outperforms:** Delivered best-ever quarter with healthy 8% EBITDA margin, showcasing resilience in weak market conditions. ## C. EBITDA Margins * **Profitability Focus Intensifies:** Strategy centered on premiumization, new product launches, and cost control is driving margin expansion across geographies. * **Domestic Replacement Drives Margins:** Remains the most profitable segment; export margins remain lower but TBR exports show potential to converge with domestic levels on favorable currency moves. ## D. Net Debt & Leverage * **Sharp Deleveraging:** Net debt halved QoQ to ₹1,300 Cr on strong cash flow, lifting financial flexibility and reducing leverage risk. * **Balance Sheet Resilience:** Net debt/EBITDA cut to 4.0x from 8.0x; long-term target remains sub-0.5x under normalized conditions, with future capex to be debt-funded through FY27–FY28. * **India Leverage Improves:** India operations saw net debt drop significantly, with net debt/EBITDA improving sharply despite prior quarter distortion. ## E. Cash Flow & Tax Rate * **Interest Outgo Timing Effect:** Standalone interest costs rose QoQ due to repayment timing, but major working capital debt reduction in final 45 days will benefit next quarter’s P&L. * **Tax Rate Shift Likely:** Current standalone tax rate at 33–34%, but management expects move to **25–26% bracket** post-MAT changes in budget, boosting future earnings power. * **Other Income One-Time Gain:** Surge in standalone other income attributed to **one-time dividend from overseas subsidiary**, not recurring. --- # 2. Volume & Demand Trends ## A. Key Figures * **India Volume Growth:** **mid-teens** YoY (Q3 standalone) · **strong double-digit** across channels & categories * **Export Growth:** **just short of 20%** YoY * **TBR Replacement Market Share:** **~30%** (management estimate) * **PCR Replacement Market Share:** **~20%** (management estimate) ## B. India Volume Growth * **Broad-Based Strength:** Robust double-digit volume growth across all product categories and channels, led by strong rural demand in PCR, two-wheeler, and farm segments. * **Truck Market Rebound:** Significant pickup in truck demand in both OEM and replacement markets, supporting mid-teens volume expansion. * **Selective OE Softness:** PCR OE growth remained muted due to deliberate exit from unprofitable accounts, though replacement and export segments offset weakness. ## C. Europe Demand Outlook * **Export Upside Expected:** Europe exports set to rise post-Enschede closure, aided by favorable trade dynamics, though FTA benefits remain unspecified. * **Modest Share Ambitions:** Company sees potential for market share gains in Europe and U.S. over 2–3 years, but expects to remain a **<3% player**, limiting absolute impact despite strong regional growth. ## D. Channel-Wise Performance * **Balanced Channel Growth:** OEM, replacement, and export channels all delivered strong performance, with exports nearing **20% growth** and inventory levels normalized. * **Sponsorship Lift:** Jersey sponsorship initiative boosted brand visibility and contributed to traction in consumer tyre segments, especially in rural markets. ## E. Market Share Trends * **Replacement Share Leadership:** Management estimates ~30% share in TBR replacement and ~20% in PCR replacement, with signs of regaining lost ground in key segments. * **Market Share Recovery:** Company believes it maintained or gained share in TBR and PCR overall, with partial reversal of prior PCR losses, though full recovery in PCR OEM remains pending. --- # 3. Product & Premiumisation ## A. Key Figures * **Vredestein Volumes:** **Highest-ever quarterly volumes** recorded * **UHP Mix in Europe:** **52%** of mix (+400 bps YoY) ## B. UHP & Vredestein Growth * **Premium Momentum:** Record Vredestein volumes signal strong consumer adoption and brand resonance in high-margin segments. * **Product Mix Shift:** Continued expansion of UHP share in Europe reflects successful premiumisation and pricing power. ## C. OEM Approvals * **Strategic Validation:** New approvals from major OEMs in India and Europe affirm product quality and strengthen premium positioning. ## D. Test Performance Credibility * **Performance Proof Point:** Podium finishes in independent European tests boost technical credibility and support OE footprint growth. --- # 4. Manufacturing & Capacity ## A. Key Figures * **India Capacity Utilisation:** **High 80s%** (PCR & TBR) * **India PCR Capacity:** **58,000 tyres/day** (+**10,500 tyres/day** expansion, ~18%) * **India TBR Capacity:** **>15,000 tyres/day** (+**3,600 tyres/day** expansion, ~20%) ## B. India Utilisation Levels * **Near-Full Utilisation:** India operations running at high 80s% capacity for both car and truck tyres, signaling strong demand and limited near-term headroom. * **Strategic Capacity Buildout:** Significant capacity expansions underway—**10,500 PCR** and **3,600 TBR tyres/day**—to meet rising demand, supported by AI-driven digitalisation for efficiency gains. ## C. Hungary Expansion * **Sufficient European Capacity:** Hungary expansion deemed adequate to cover demand for several years, even as Enschede closure proceeds. ## D. Enschede Closure Transition * **On-Track Restructuring:** Enschede plant closure set for end-June 2026 (Q1 FY'27), with product line transitions to Hungary and India already in motion. * **H2 FY'27 Benefits Expected:** Operational and cost benefits from the transition anticipated to materialize in the second half of FY'27. --- # 5. Capex & Investment ## A. Key Figures * **Growth Capex (FY'27):** **₹2,000 Cr** (part of multi-year ₹5,800 Cr plan) * Total Capex (FY'27 est.): ~₹3,000 Cr consolidated * **Next Year Capex (FY'27 est.):** **~₹3,000 Cr** consolidated (growth + maintenance + Hungary) * **Capex per Tonne:** **₹17 Cr/MT** (current projects) vs. ₹5–12 Cr/MT (historical) * **Capacity Addition:** **~350 TPD** from new investments ## B. Growth Capex Plan * **Strategic Expansion:** Multi-year ₹5,800 Cr capex in AP to boost PCR and TBR capacity, driven by exhausted debottlenecking options and need for civil construction. * **Global-Oriented Output:** New capacities targeting global OEMs in India, Europe, and the U.S., emphasizing high-end, export-ready production standards. * **No Strategic Shift:** Large capex reflects structural necessity, not departure from prior "bite-sized" investment discipline; transparency on long-term plan enhances visibility. * **Hungary Momentum:** PCR expansion progressing on track, with demand expected to accelerate as ramp-up continues. ## C. Capex per Tonne Cost * **Elevated Unit Costs:** Higher capex intensity at **₹17 Cr/MT** due to inflation and adoption of advanced technology, marking a step-up from prior efficiency benchmarks. ## D. Revenue Ramp-Up Timeline * **Earlier Revenue Contribution:** Revenue from new capacity to start in **FY'28**, earlier than previously assumed, due to anticipated FY'27 constraints. * **Phased Ramp-Up:** Full operational scale expected only in **H2 FY'29**, with full financial benefits and ROI realization targeted for **FY'30**. --- # 6. Pricing & Input Costs ## A. Key Figures * **Raw Material Cost Outlook:** **Flattish** in India Q4 · **Short sourcing cycle** (India: <1 quarter P&L impact) ## B. Replacement Market Pricing * **Pricing Discipline Maintained:** Replacement market pricing remains stable with no recent changes, supported by favorable raw material trends and inherent price stickiness during cost declines. * **Profitability Catalysts:** Anticipated duty reductions under trade agreements could boost U.S. margins, which had been compressed despite stable revenues. * **Structural Pricing Power:** Pricing adjusts upward with raw material cycles and shows resilience on the downside, with **mid-single digit annual increases** likely needed under stable cost environments to meet return targets. ## C. Raw Material Trends * **Near-Term Cost Stability:** Indian raw material costs expected to remain steady in Q4, though global volatility and **sharp rupee fluctuations** create forecasting uncertainty. * **Regional Procurement Divergence:** Rising global rubber prices impact India within a quarter due to short cycles, while Europe faces a **~one-quarter lag** in cost pass-through. --- # 7. Risks & Market Conditions ## A. Key Figures * **Q3 A&P and Sales Promotion Expenses:** **₹150 Cr** (elevated due to activation and sponsorship) ## B. European Demand Weakness * **Stabilizing but Still Weak:** European demand remains in low single-digit negative territory, showing clear improvement from prior mid to high single-digit declines across passenger car, agri, and truck segments. * **Recovery Pushed Out:** Despite optimism among peers for a rebound by late FY'25, the company continues to face a challenging environment, particularly in key markets like the Netherlands. * **Strategic Trade Tailwind:** The India-Europe trade deal is viewed as highly strategic, aligning with Apollo’s regional footprint and potential for future demand recovery. ## C. A&P Spend Volatility * **Sponsorship Driving Brand Pull:** Elevated A&P spend is generating strong brand visibility and distribution gains, especially in rural consumer tyre markets, supported by the BCCI jersey partnership. * **Near-Term Pressure, Long-Term Normalization:** Profitability in India was temporarily impacted by upfront BCCI sponsorship costs; A&P is expected to normalize by FY'27 after current contracts expire. * **Baseline A&P Discipline:** Excluding current anomalies, typical A&P spend remains tightly managed at **2% of sales**, reflecting underlying cost control. ## D. No Raw Material Hedging * **Speculation Avoidance:** The company maintains no hedging policy for rubber or crude oil, citing limited delivery-linked contracts and a deliberate stance against speculative positions. --- # 8. Guidance & Outlook ## A. Key Figures * A&P Spend: 2.5% of sales (normalized, stabilizing by FY'27) * **European Market Growth:** **1%–2%** long-term trend * **Capex Outlook:** **FY'28 potentially >₹3,000 Cr** (peak in cycle) · FY'27 & FY'28 high-spending years · FY'29 tapering * ROCE: 13.5% current vs. 15% target (achieved in 2 of 5 years in FY'26 plan) * **Tax Rate Transition:** Expected from **FY'27**, pending tax team assessment ## B. FY'27 Demand Outlook * **Sustained Demand Momentum:** Healthy double-digit growth in January signals continued strength into Q4, underpinning a positive FY'27 demand outlook. * **Capacity Discipline:** No near-term European expansion beyond Hungary; aligned with modest 1–2% market growth expectations. ## C. Margin Improvement Path * **Margin Inflection Ahead:** Full benefits from restructuring and plant closures expected to boost European profitability from **H2 FY'27**, though no specific margin guidance provided. ## D. ROCE & Cash Flow Targets * **Strategic Focus on Capital Efficiency:** Five-year plan (FY'26–FY'31) prioritizes **ROCE improvement** and **free cash flow generation** despite elevated capex in FY'27–FY'28. * **Capex Peaks Before Decline:** Capital spending to peak in **FY'28**, with meaningful tapering expected in **FY'29**.